Dexcom Expands Nondiabetic CGM Market with Nutrisense Acquisition and Product Redesign
Dexcom announced plans to acquire Nutrisense, a continuous glucose monitoring (CGM) startup targeting nondiabetics. Additionally, Dexcom is redesigning its over-the-counter Stelo CGM device with FDA-cleared features including pattern recognition and AI coaching.
Tickers: $DXCM
Topics: acquisition CGM FDA clearance health tech wearables